News

News

Find out more about financial and general topics of Sinclair Pharma Plc.

Show all News

Jayne Burrell talks to The Brief.

Our Group General Counsel and Company Secretary Jayne Burrell talks to The Brief – the number one place for; legal opinions, interviews and updates. 

Ellansé Approved for Brazil

Sinclair Pharma plc (AIM:SPH.L) (“Sinclair” or the “Group”), the international aesthetics company, is pleased to announce that it has received regulatory approval of Ellansé® by ANVISA in Brazil.

Pre – Close Trading Update

Pre-Close Trading Update 20% growth in revenue to £45.3million Strong performance across all key brands Return to EBITDA profitanticipated Download Update

Trading Statement 2017

Trading Statement 2017 20% growth in revenue to £45.3million Strong performance across all key brands Return to EBITDA profitanticipated Download Report

Interim Results 2017 Presentation

Interim Results 2017 Presentation 19th September 2017 – Further progress in building a high growth, global pure – play aesthetics business  Download Presentation

Interim Results 2017

Interim Results 2017 Interim Results – Strong underlying growth from key products, on track to meet full year guidance for EBITDA profit in…

Sinclair Network

At Sinclair we strive to provide the highest standards of training and ongoing support, working in partnership with our physician customers to deliver patients unparalleled clinical results and industry leading safety standards.